⌘K

Home/Filings/4/0000875320-25-000059

4//SEC Filing

Arbuckle Stuart A 4

Accession 0000875320-25-000059

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:06 PM ET

Size

5.4 KB

Accession

0000875320-25-000059

Insider Transaction Report

Form 4

Period: 2025-02-12

VERTEX PHARMACEUTICALS INC / MAVRTX

Arbuckle Stuart A

EVP\Chief Commercial Officer

Transactions

Award
Common Stock
2025-02-12+7,903→ 77,446 total

Holdings

Common Stock
(indirect: By 401(k))
140

Footnotes (1)

[F1]Restricted stock unit award that vests in installments beginning on 02/24/2026.

Documents

1 file

4
wk-form4_1739567177.xmlPrimary
FORM 4

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001557290

Filing Metadata

Form type: 4
Filed: Feb 13, 7:00 PM ET
Accepted: Feb 14, 4:06 PM ET
Size: 5.4 KB

View on SEC.gov